Noncardiac chest pain

被引：7

作者：

Wong W.-M. ^{[1
]}

Fass R. ^{[1
]}

机构：

[1] Southern Arizona VA Hlth. Care Syst., Tucson, AZ 85723

来源：

Current Treatment Options in Gastroenterology | 2004年 / 7卷 / 4期

关键词：

Irritable Bowel Syndrome; Lower Esophageal Sphincter; Main Side Effect; Main Drug Interaction; Rabeprazole;

D O I：

10.1007/s11938-004-0013-5

中图分类号：

学科分类号：

摘要：

Noncardiac chest pain (NCCP) is a common condition with significant morbidity and economic implications. Psychological factors, gastroesophageal reflux disease (GERD), alteration in pain perception, and esophageal dysmotility play an important role in the pathogenesis of the disorder. Proton pump inhibitor (PPI) therapy is the most effective medical intervention for the treatment of GERD-related NCCP, as well as the most cost-effective diagnostic strategy for this condition. Pain modutalors such as tricyclic antidepressants, trazodone, and selective serotonin reuptake inhibitors infer a visceral analgesic effect and consequently are the treatment of choice for patients with non-GERD-related NCCP. Furthermore, cognitive behavioral therapy has also been shown to be useful in the management of subset of patients with non-GERD-related NCCP. Newer therapeutic modalities and interventions such as lower esophageal sphincter injection of botulinum toxin in NCCP patients with spastic esophageal motility disorders, theophylline, and 5-HT4 receptor agonists may supplement or replace current treatment for non-GERD-related NCCP. Future compounds may include new visceral analgesics or medications that interfere with the development of peripheral or central sensitization. Copyright © 2004 by Current Science Inc.

引用

页码：273 / 278

页数：5

共 29 条

[1]

Fass R., Malagon I., Schmulson M., Chest pain of esophageal origin, Curr. Opin. Gastroenterol., 17, pp. 376-380, (2001)

[2]

Fass R., Chest pain of esophageal origin, Curr. Opin. Gastroenterol., 18, pp. 464-470, (2002)

[3]

Locke III G.R., Talley N.J., Fett S.L., Et al., Prevalence and clinical spectrum of gastroesophageal reflux: A population-based study in Olmsted County, Minnesota, Gastroenterology, 112, pp. 1448-1456, (1997)

[4]

Richter J.E., Bradley L.A., Castell D.O., Esophageal chest pain: Current controversies in pathogenesis, diagnosis, and therapy, Ann. Intern. Med., 110, pp. 66-78, (1989)

[5]

Dekel R., Pearson T., Wendel C., Et al., Assessment of oesophageal motor function in patients with dysphagia or chest: The clinical outcomes research initiative experience, Aliment. Pharmacol. Ther., 18, pp. 1083-1089, (2003)

[6]

Clouse R.E., Richter J.E., Heading R.C., Et al., Functional esophageal disorders, Gut, 45, SUPPL. II, (1999)

[7]

Fass R., Tougas G., Functional heartburn: The stimulus, the pain, and the brain, Gut, 51, pp. 885-895, (2002)

[8]

Richter J.E., Obrecht W.F., Bradley L.A., Et al., Psychologic comparison of patients with nutcracker esophagus and irritable bowel syndrome, Dig. Dis. Sci., 31, pp. 131-138, (1986)

[9]

Cannon R.O., Quyymi A.A., Mincemoyer R., Et al., Imipramine in patients with chest pain despite normal coronary angiograms, N. Engl. J. Med., 330, pp. 1411-1417, (1994)

[10]

Squillace S.J., Young M.F., Sanowski R.A., Single-dose omeprazole as a test for noncardiac chest pain, Gastroenterology, 104, (1993)

← 1 2 3 →